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PMN infiltration and lipid peroxidation, respectively. TempolTempol, a membrane-permeable radical scavenger, reduces
reduced the histologic evidence of renal damage associatedoxidant stress-mediated renal dysfunction and injury in the rat.
with ischemia/reperfusion and caused a substantial reductionBackground. The generation of reactive oxygen species
in the staining for nitrotyrosine and PARS, suggesting reduced(ROS) contributes to the pathogenesis of renal ischemia-reper-
nitrosative and oxidative stress. In vitro, tempol significantlyfusion injury. The aim of this study was to investigate the
attenuated H2O2-mediated decrease in mitochondrial respira-effects of tempol in (1) an in vivo rat model of renal ischemia/
tion and increase in LDH release from rat PT cells, indicatingreperfusion injury and on (2) cellular injury and death of rat
a reduction in cell injury and death. Both in vivo and in vitro,renal proximal tubular (PT) cells exposed to oxidant stress in
the beneficial actions of tempol were similar to those obtainedthe form of hydrogen peroxide (H2O2).
using the Fe21 chelator DEF. However, coadministration ofMethods. Male Wistar rats underwent bilateral renal pedicle
clamping for 45 minutes followed by reperfusion for six hours. DEF and tempol did not produce any additional beneficial
Tempol (30 mg/kg/h), desferrioxamine (DEF; 40 mg/kg/h), or actions against renal ischemia/reperfusion injury or against oxi-
a combination of tempol (30 mg/kg/h) and DEF (40 mg/kg/h) dative stress-mediated PT cell injury/death.
were administered prior to and throughout reperfusion. Plasma Conclusion. Our results suggest that the membrane-perme-
concentrations of urea, creatinine, Na1, g-glutamyl transferase able radical scavenger, tempol, reduces the renal dysfunction
(gGT), aspartate aminotransferase (AST), and urinary Na1 and injury associated with ischemia/reperfusion of the kidney.
and N-acetyl-b-d-glucosaminidase (NAG) were measured for
the assessment of renal function and reperfusion injury. Kidney
myeloperoxidase (MPO) activity and malondialdehyde (MDA)
Renal ischemia/reperfusion injury is one of the mostlevels were measured for assessment of polymorphonuclear
common causes of acute renal failure (ARF), initiating(PMN) cell infiltration and lipid peroxidation, respectively.
Renal sections were used for histologic grading of renal injury a complex and interrelated sequence of events, resulting
and for immunohistochemical localization of nitrotyrosine and in injury to and the eventual death of renal cells [1, 2].
poly(ADP-ribose) synthetase (PARS). Primary cultures of rat Although reperfusion is essential for the survival of is-PT cells were incubated with H2O2 (1 mmol/L for 4 h) either
chemic tissue, reperfusion itself causes additional cellin the absence or presence of increasing concentrations of
injury (reperfusion-injury) [3], which has been attributedtempol (0.03 to 10 mmol/L), DEF (0.03 to 10 mmol/L), or a
combination of tempol (3 mmol/L) or DEF (3 mmol/L). PT cell to the generation of reactive oxygen species (ROS) inter
injury and death were determined by evaluating mitochondrial alia [3–5]. Furthermore, it appears that the proximal
respiration and lactate dehydrogenase (LDH) release, respec- tubule (PT) appears to be particularly susceptible to thetively.
reperfusion-injury mediated by ROS [2, 3].Results. In vivo, tempol significantly reduced the increase
The hypothesis that the generation of ROS contributesin urea, creatinine, gGT, AST, NAG, and FENa produced by
renal ischemia/reperfusion, suggesting an improvement in both to renal ischemia/reperfusion injury is supported by
renal function and injury. Tempol also significantly reduced many studies demonstrating the beneficial effects of vari-
kidney MPO activity and MDA levels, indicating a reduction in ous interventions, which either reduce the generation or
reduce the effects of ROS [3]. These therapeutic strate-
gies include the administration of antioxidant enzymesKey words: renal injury, proximal tubule, reactive oxygen species, des-
ferrioxamine, ischemia, acute renal failure. such as superoxide dismutase (SOD) and catalase (CAT)
[6, 7], ROS scavengers such as mannitol [8], and agentsReceived for publication June 14, 1999
that prevent the generation of ROS such as desferrioxa-and in revised form February 7, 2000
Accepted for publication March 14, 2000 mine (DEF) [8, 9] and allopurinol [10]. However, the
potential benefits of the systemic administration of theseÓ 2000 by the International Society of Nephrology
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agents, for example, SOD, are limited for the following METHODS
reasons [11]: (1) SOD does not permeate biological Animal preparation
membranes and is therefore not able to reduce the detri-
In vivo studies were carried out using 83 male Wistarmental effects of superoxide anions, which are produced
rats (Tuck, Rayleigh, Essex, UK) weighing 230 to 320 gintracellularly. (2) Superoxide anions produced within
and receiving a standard diet and water ad libitum andcells (for example, via uncoupling of the mitochondrial
cared for in accordance with the Home Office Guidancerespiratory chain) do not leave the cell in which they
in the Operation of the Animals (Scientific Procedures)have been generated, but remain potentially injurious
Act 1986, published by HMSO (London, UK). All ani-to intracellular cell structures. (3) SOD dismutates super-
mals were anesthetized with sodium thiopentone (Intra-oxide anions into hydrogen peroxide (H2O2), which, in
valt Sodium, 120 mg/kg intraperitoneally; Rhone Me-turn, can generate the highly toxic hydroxyl radical via
rieux Ltd., Essex, UK), and anesthesia was maintainedthe Fenton or Haber-Weiss reactions and which also
by supplementary infusions of sodium thiopentone. Thecontribute to renal reperfusion injury [5]. To overcome
animals were placed onto a thermostatically controlledthese limitations, SOD mimetics, which scavenge radicals
heating mat (Harvard Apparatus Ltd., Kent, UK), andand permeate biological membranes, are of small molec-
body temperature was maintained at 38 6 18C by meansular weight and have the potential to be useful in condi-
of a rectal probe attached to a homeothermic blanket. Ations associated with ischemia/reperfusion injury of the
tracheotomy was performed to maintain airway patencykidney and associated acute renal failure (ARF).
and to facilitate spontaneous respiration. The right ca-Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-
rotid artery was cannulated (PP50, I.D. 0.58 mm; Portex,oxyl or 4-hydroxy-tempo) is a stable piperidine nitroxide
Kent, UK) and connected to a pressure transducerand is a water-soluble analogue of the spin label tempo,
which is widely employed in electron spin resonance (Senso-Nor 840; Senso-Nor, Horten, Norway) for the
spectroscopy [12]. It has a relatively low molecular measurement of mean arterial blood pressure (MAP)
weight (172) and permeates biological membranes [13]. and derivation of the heart rate (HR) from the pulse
Tempol scavenges superoxide anions in vitro [13] and waveform, which were displayed on a data acquisition
may act as a genuine “SOD-mimetic” [14]. Tempol also system (MacLab 8e; AD Instruments, Hastings, UK)
reduces the formation of hydroxyl radicals either by scav- installed on an Apple MacIntosh computer. MAP and
enging superoxide anions or by reducing the intracellular HR were monitored for the duration of each experiment.
concentrations of Fe21 and, hence, the formation of hy- The jugular vein was cannulated (PP25, I.D. 0.40 mm;
droxyl radicals via the Fenton or Haber-Weiss reactions Portex) for the administration of drugs. A midline lapa-
[15–17]. rotomy was performed, and the bladder was cannulated
To date, there has been relatively little research into (PP90, I.D. 0.76 mm; Portex). Both kidneys were located,
any protective actions afforded by tempol within the and the renal pedicles, containing the artery, vein, and
kidney or in specific renal structures such as the PT, nerve supplying each kidney, were carefully isolated.
under normal or pathophysiologic conditions. One re-
port has described how a two-week administration of Renal ischemia/reperfusion
tempol reduced both hypertension and renal excretion Rats were allowed to stabilize for 30 minutes before
of 8-iso-prostaglandin F2a (used as an marker of oxidative they were subjected to bilateral renal occlusion for 45
stress) in spontaneously hypertensive rats (SHRs) [18]. minutes using artery clips to clamp the renal pedicles.
We have recently discovered that tempol attenuates re-
Reperfusion commenced once the artery clips were re-
nal dysfunction and injury caused by endotoxin in the
moved (control animals). Occlusion was verified visuallyrat [19] and during hemorrhagic shock [20]; the patho-
by change in the color of the kidneys to a paler shadegenesis of which involves an enhanced formation of
and reperfusion by a blush. Other rats, which underwentROS. Furthermore, we have also shown that tempol
identical surgical procedures similar to control animalsreduces infarct size in rodent models of regional myocar-
but did not undergo bilateral renal clamping, were sub-dial ischemia/reperfusion [20]. The aim of this study was
jected to sham operation (sham operated) and weretherefore to investigate whether tempol (1) can reduce
maintained under anesthesia for the duration of the ex-the renal dysfunction and injury associated with ische-
periment. At the end of all experiments, animals weremia/reperfusion of the rat kidney in vivo, and (2) can
killed by an overdose of sodium thiopentone.protect cultured rat PT cells against oxidant stress in
vitro. To elucidate putative mechanisms by which tempol
Experimental protocolmay exert beneficial actions against renal ischemia/reper-
Upon completion of surgical procedures, the animalsfusion injury, its effects were compared with those of DEF,
were randomly allocated to the eight groups describedan iron chelator that binds and subsequently reduces the
in Table 1. At one minute before commencement ofavailability of Fe21 and that has previously been shown
to protect rabbit kidneys against ischemic injury [8, 9]. reperfusion, animals received a bolus injection of either
Chatterjee et al: Tempol reduces renal dysfunction and injury660
Table 1. Renal ischemia/reperfusion model and intervention: Experimental design
Ischemia Reperfusion
Group N time min time hours Treatment Dose
1 11 a a Sham-operated Saline only (4 mL/kg/h)
2 14 45 6 Control Saline only (4 mL/kg/h)
(45 min ischemia 1
6 h reperfusion)
3 12 45 6 Control 1 tempol 30 mg/kg bolus
30 mg/kg/h infusion
4 6 a a Tempol 30 mg/kg bolus
sham-operated 30 mg/kg/h infusion
5 12 45 6 Control 1 DEF 40 mg/kg bolus
40 mg/kg/h infusion
6 6 a a DEF 40 mg/kg bolus
sham-operated 40 mg/kg/h infusion
7 12 45 6 DEF 1 tempol 40 mg/kg DEF 1 30 mg/kg tempol bolus
40 mg/kg/h DEF 1 30 mg/kg/h tempol infusion
8 6 a a DEF 1 tempol 40 mg/kg DEF 1 30 mg/kg tempol bolus
sham-operated 40 mg/kg/h DEF 1 30 mg/kg/h tempol infusion
Sham-operated or control animals were administered a bolus injection of either vehicle (saline), tempol, desferrioxamine (DEF), or a co-administration of tempol
and DEF one minute before commencement of reperfusion. The corresponding groups then received a continuous infusion of either vehicle (saline), tempol, DEF,
or a combination of tempol and DEF throughout the reperfusion period.
a These animals did not undergo renal clamping (sham-operated)
vehicle (saline, 4 mL/kg, IV), tempol (30 mg/kg in saline, function [23, 24]. Plasma concentrations of g-glutamyl
transferase (gGT) and aspartate aminotransferase (AST),IV), DEF (40 mg/kg in saline, IV), or DEF (40 mg/kg
in saline, IV) in combination with tempol (30 mg/kg in enzymes that are both located in the PT [25], were used
as indicators of renal reperfusion-injury (Discussion sec-saline, IV). The corresponding groups then received a
continuous infusion of one of the following throughout tion). Total plasma bilirubin (BIL) and alanine amino-
transferase (ALT; a specific marker for hepatic paren-the reperfusion period: vehicle (saline, 4 mL/kg/h, IV),
tempol (30 mg/kg/h in saline, IV), DEF (40 mg/kg/h in chymal injury) were also measured and used as indicators
of liver function and injury, respectively (Discussion sec-saline, IV), or tempol and DEF in combination (30 and
40 mg/kg/h, respectively, in saline, IV). To elucidate the tion) [24, 26].
Urine samples were collected during the reperfusioneffects of tempol or DEF on cardiovascular hemodynam-
ics and organ function in sham-operated rats, respective period, and the volume of urine produced was recorded.
Urine concentrations of Na1 were measured (Vetlabgroups of animals received the treatments described pre-
viously in this article and as outlined in Table 1. The Services) and were used in conjunction with plasma Na1
concentrations to calculate fractional excretion of Na1concentration of tempol administered in vivo was based
on those previously demonstrated by us to provide sig- (FENa) using standard formulae, which was used as an
indicator of tubular function. Concentrations of urinarynificant protection against myocardial ischemia/reperfu-
sion injury in an in vivo rat model [21]. Similarly, the N-acetyl-b-d-glucosaminidase (NAG), an indicator of
tubular damage [27], were also measured (Laboratory ofconcentration of DEF used was identical to that which
we have previously used to provide significant protection Pharmacology, University of Lisbon, Lisbon, Portugal).
against hepatic ischemia/reperfusion injury in in vivo rat
Determination of myeloperoxidase activityand rabbit models [22].
In all of the groups of animals, hemodynamic parame- Myeloperoxidase (MPO) activity in kidneys was used
as an indicator of polymorphonuclear (PMN) cell infil-ters (MAP and HR) were recorded for the duration of
the experiment. tration using a method previously described [28]. Briefly,
at the end of the experiments, kidney tissue was weighed
Measurement of biochemical parameters and homogenized in a solution containing 0.5% (wt/vol)
hexadecyltrimethylammonium bromide dissolved in 10At the end of the reperfusion period, blood (1 mL)
samples were collected via the carotid artery into S1/3 mmol/L potassium phosphate buffer (pH 7.4) and centri-
fuged for 30 minutes at 20,000 g at 48C. An aliquot oftubes containing serum gel. The samples were centri-
fuged (6000 r.p.m. for 3 min) to separate plasma. All supernatant was then removed and added to a reaction
mixture containing 1.6 mmol/L tetramethylbenzidineplasma samples were analyzed for biochemical parame-
ters within 24 hours after collection (Vetlab Services, and 0.1 mmol/L hydrogen peroxide (H2O2). The rate of
change in absorbance was measured spectrophotometri-Sussex, UK). Plasma concentrations of urea and creati-
nine were measured as indicators of impaired glomerular cally at 650 nm. MPO activity was defined as the quantity
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of enzyme required to degrade 1 mmol of H2O2 at 378C (DBA, Milan, Italy), respectively. Kidney sections were
then used for the immunohistochemical localization ofand was expressed in mU/100 mg wet tissue.
nitrotyrosine and poly(ADP-ribose) synthetase (PARS).
Determination of malondialdehye levels Tyrosine nitration, which was used as an index of the
nitrosylation of protein by peroxynitrite and/or ROS,Levels of malondialdehyde (MDA) in kidneys were
determined as an indicator of lipid peroxidation follow- was determined using immunohistochemistry as pre-
viously described [31]. Sections were incubated over-ing a protocol described previously [29]. Briefly, kidney
tissue was weighed and homogenized in a 1.15% (wt/ night with a 1:1000 dilution of primary antinitrotyrosine
antibody (DBA). PARS activation was assessed using avol) KCl solution. A 100 mL aliquot of homogenate was
then removed and added to a reaction mixture con- protocol previously described [32] in which sections were
incubated overnight with a 1:500 dilution of primarytaining 200 mL 8.1% (wt/vol) lauryl sulfate, 1.5 mL 20%
(vol/vol) acetic acid (pH 3.5), 1.5 mL 0.8% (wt/vol) thio- anti-PARS antibody (DBA). Separate sections were also
incubated with control solutions consisting of PBS alonebarbituric acid, and 700 mL distilled water. Samples were
then boiled for one hour at 958C and centrifuged at or a 1:500 dilution of nonspecific purified rabbit IgG
(DBA). Specific labeling was detected using a biotin-3000 3 g for 10 minutes. The absorbance of the superna-
tant was measured spectrophotometrically at 650 nm. conjugated goat antirabbit IgG (DBA) and avidin-biotin
peroxidase (DBA). Samples were then viewed under aMDA levels were expressed as mmol/L MDA/100 mg
wet tissue. light microscope.
Isolation and culture of rat proximal tubule cellsHistologic evaluation
At postmortem, a 5 mm section of kidney was removed Proximal tubular cells were isolated from kidneys ob-
tained from 18 male Wistar rats (weighing 260 to 350 g)and placed in formalin and processed through to wax.
Five millimeter sections were cut and stained with hema- using collagenase digestion, differential sieving, and Per-
coll density centrifugation as described previously [33–35].toxylin and eosin. Histologic assessment of tubular ne-
crosis was determined semiquantitatively using a method Briefly, kidney cortex was separated and washed with
Hank’s buffered salt solution (GIBCO BRL/Life Tech-modified from McWhinnie et al [30]. Random cortical
fields were observed using a 320 objective. A graticule nologies, Paisley, Scotland, UK) to remove blood and
urine and was chopped into small pieces. These weregrid (25 squares) was used to determine the number of
line intersects involving tubular profiles. One hundred digested in medium consisting of a 1:1 mixture of Dulbec-
co’s modified Eagle’s medium and Ham’s F12 nutritionalintersections were examined for each kidney, and a score
from 0 to 3 was given for each tubular profile involving mixture (DMEM/Ham’s F12; GIBCO BRL/Life Tech-
nologies) containing collagenase A (0.1% wt/vol; Boeh-an intersection: 0 5 normal histology (Fig. 5A); 1 5
tubular cell swelling, brush border loss, nuclear conden- ringer Mannheim, Sussex, UK) for 20 minutes at 378C.
The resulting suspension was filtered through metal sievessation, with up to one third of tubular profile showing
nuclear loss (Fig. 5B); 2 5 same as for score 1, but greater of decreasing pore size (300, 150, and 75 mm; Endecotts,
London, UK) to remove glomeruli and larger undigestedthan one third and less than two thirds of tubular profile
shows nuclear loss (Fig. 5C); 3 5 greater than two thirds fragments, after which the filtrate was washed with
DMEM/Ham’s F12. The cell pellet was then resuspendedof tubular profile shows nuclear loss (Fig. 5D). The total
score for each kidney was calculated by addition of all in a Percoll solution (30% vol/vol Percoll prepared in
DMEM/Ham’s F12, starting density 1.044 g/mL; Sigma100 scores.
Chemical Co., Dorset, UK) and centrifuged at 13,000
Immunohistochemical localization of nitrotyrosine r.p.m. for 30 minutes at 48C. Percoll density centrifuga-
and poly(ADP-ribose) tion produced three distinct bands at densities 1.040,
1.060, and 1.065 g/mL from which the 1.060 g/mL bandRat kidneys fixed in 10% (wt/vol) neutral buffered
paraformaldehyde and 8 mm sections were prepared has previously been shown to contain single and small
clumps of PT cells at a purity of greater than 96% [33].from paraffin-embedded tissues. After deparaffination,
endogenous peroxidase was quenched using 0.3% (vol/ This band was removed, and the cells were washed with
DMEM/Ham’s F12 before the cell pellet was resus-vol) H2O2 in 60% methanol for 30 minutes. The sections
were permeablized using 0.1% (wt/vol) Triton X-100 in pended in minimum essential medium (MEM; con-
taining l-valine substituted for d-valine; GIBCO BRL/phosphate-buffered saline (PBS; 0.01 mol/L, pH 7.4) for
20 minutes. Nonspecific adsorption was minimized by Life Technologies) and an aliquot removed for determi-
nation of cell number and viability using the Trypan blueincubating sections in 2% (vol/vol) normal goat serum
in PBS for 20 minutes. Endogenous avidin- and biotin- exclusion method. The remaining suspension was diluted
with MEM containing 10% (vol/vol) fetal calf serumbinding sites were blocked by sequential incubation for
15 minutes with avidin (DBA, Milan, Italy) and biotin (FCS; Sigma Chemical Co.) and seeded at a density of
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1 3 105 cells/mL. Rat PT cells were cultured in MEM cally by measurement of absorbance at 550 nm using
an Anthos Labtec microplate reader (Labtec, Uckfield,containing 10% (vol/vol) FCS in a humidified 5% CO2/
95% air atmosphere at 378C. Medium was changed every Sussex, UK). Results were expressed as mitochondrial
respiration as a percentage of that of control cells (that48 hours until the cells reached confluence.
is, those not exposed to H2O2), which was taken as 100%.
Experimental design
Measurement of cytotoxicityTo investigate the effect of tempol, DEF, and DEF
coadministered with tempol on H2O2-mediated cell in- Lactate dehydrogenase assay. Cell death was deter-
mined by measurement of lactate dehydrogenase (LDH)jury and death, confluent cultures of PT cells were prein-
cubated (10 min at 378C) with tempol (0.03 to 10 released into the incubation medium due to the loss
of membrane integrity using a commercially availablemmol/L), DEF (0.03 to 10 mmol/L), or DEF (3 mmol/L)
in combination with tempol (3 mmol/L). The ranges of cytotoxicity detection kit (Boehringer Mannheim) as
previously described [35]. The assay operates on theconcentrations of tempol and DEF were based on those
previously shown in this laboratory to reduce on H2O2- principle that LDH released from damaged cells reduces
NAD to NADH and H1 by oxidation of lactate to pyr-mediated cell injury and death in (1) cultured rat cardiac
myoblasts (tempol [21]) and (2) primary cultures of rat uvate, followed by the transfer of 2 H from NADH and
H1 to a yellow tetrazolium salt (2-[4-iodophenyl]-3-[4-PT cells (DEF [35]). PT cell cultures were then incubated
with H2O2 (1 mmol/L) for four hours, after which cellular nitrophenyl]-5-phenyltetrazolium chloride) in the pres-
ence of a catalyst, forming a formazan. Thus, an increaseinjury and death were assessed as described later in this
article, which we have previously shown to produce a in LDH in the medium correlates directly with increased
formazan production, which unlike the tetrazolium salt,significant but submaximal inhibition of mitochondrial
respiration and subsequently, the release of the cytosolic can be measured spectrophotometrically at 492 nm.
Briefly, an aliquot of incubation medium was trans-enzyme LDH into the supernatant [35]. Upon comple-
tion of incubations, cellular injury and death were as- ferred into a 96-well plate, and reaction buffer was added
to each well. The mixture was incubated for 30 minutessessed using the spectrophotometric assays described
later in this article. at room temperature. The reaction was stopped by the
addition of 2 mol/L HCl, and absorbance was measured
Measurement of cellular injury spectrophotometrically at 492 nm using an Anthos Lab-
tec microplate reader (Labtec). Results were expressedMTT assay. As previously described [35], cellular in-
jury was determined indirectly by measurement of the as percentage of the total LDH released from cells incu-
bated with 1% (wt/vol) Triton X-100.mitochondrial-dependent conversion of MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide;
MaterialsSigma Chemical Co.) into a formazan, which unlike the
tetrazolium salt, can be measured spectrophotometri- Unless otherwise stated, all compounds used in this study
were purchased from Sigma-Aldrich Company Ltd. (Poole,cally at 550 nm. The reduction of MTT, mainly by the
mitochondrial complexes I and II, is a useful indicator Dorset, UK). All solutions used for in vivo infusions were
prepared using nonpyrogenic saline (0.9% wt/vol NaCl;of the general metabolic status of the cell, which is depen-
dent on mitochondrial respiration. This measurement Baxter Healthcare Ltd., Thetford, Norfolk, UK).
was therefore used as an indicator of mitochondrial res-
Statistical analysispiration and hence cellular viability. Although the reduc-
tion of MTT appears to be mainly via the mitochondrial All values are expressed as mean 6 SEM for N obser-
vations. For the in vivo studies, each data point repre-complexes I and II, it may also involve NADH- and
NADPH-dependent energetic processes, which occur sents biochemical measurements obtained from 6 to 12
separate animals (Table 1). For histologic scoring, eachoutside of the mitochondrial inner membrane [36]. Thus,
this method cannot be used to separate the effect of data point represents an analysis of kidneys taken from
6 to 12 individual animals. For immunohistochemicalfree radicals, oxidants, or other factors on the individual
enzymes in the mitochondrial respiratory chain, but is analysis, the figures shown are representative of at least
six experiments performed on different experimentalnevertheless a useful assay for monitoring changes in
the general energetic status of the cells. days. For in vitro studies involving PT cell cultures, mea-
surements were taken from cultures obtained from 18Briefly, cells were incubated with MTT (0.2 mg/mL in
PBS) for one hour at 378C, after which the MTT solution separate isolations. For the determination of cellular
injury (MTT assay) and cell death (LDH assay), experi-was removed by aspiration. The cells were then solubi-
lized in dimethyl sulfoxide, and an aliquot was trans- ments were performed in triplicate. Statistical analysis
was carried out using GraphPad Prism/Instat 1.1 (Graph-ferred into a 96-well plate, after which the reduction of
MTT to formazan was quantitated spectrophotometri- Pad Software, San Diego, CA, USA). Data were ana-
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lyzed using one-way analysis of variance followed by
Dunnett’s post hoc test, and a P value of less than 0.05
was considered to be significant (NS is nonsignificant).
RESULTS
Renal ischemia/reperfusion model
This study was carried out using 83 male Wistar rats,
4 of which died during the course of the experiments,
giving an overall mortality of 4.8%. All results from rats
that died were excluded from the data analysis, and N
provided in the text and in Table 1 refers to “survivors”
of the entire experimental period only. Administration
of tempol or DEF or the combination of DEF and tem-
pol, prior to and continued throughout reperfusion, did
not have a significant effect on MAP or HR in compari-
son with those obtained from sham-operated animals or
control animals (data not shown).
Effect of tempol and DEF on ischemia/
reperfusion-mediated glomerular dysfunction
Animals that underwent 45-minute renal pedicle clamp-
ing followed by six-hour reperfusion exhibited significant
increases in the plasma concentrations of urea and creati-
nine compared with sham-operated animals (Fig. 1), sug-
gesting a significant degree of glomerular dysfunction.
During reperfusion, plasma levels of urea increased by ap-
proximately fourfold from 7 6 1 mmol/L (sham-operated)
to 33 6 2 mmol/L (controls; N 5 11 to 14, P , 0.05; Fig.
1A). Plasma creatinine concentrations increased by ap-
proximately sixfold from 34 6 2 (sham-operated) to 212 6
Fig. 1. Alterations in (A) plasma urea and (B) plasma creatinine con-10 mmol/L (controls; N 5 11 to 14, P , 0.05; Fig. 1B). centrations during renal ischemia/reperfusion in the presence of tempol
Tempol, administered prior to and continually through- (TEMP, 30 mg/kg IV bolus injection followed by infusion of 30 mg/
kg/h throughout the reperfusion period) or desferrioxamine (DEF; 40out reperfusion, produced significant reductions in plasma
mg/kg IV bolus injection followed by infusion of 40 mg/kg/h), or a
urea and creatinine concentrations compared with values combination of both tempol and DEF (30 mg/kg tempol/40 mg/kg DEF
IV bolus injection followed by infusion of 30 mg/kg/h tempol/40 mg/obtained from control animals (Fig. 1), reducing urea
kg/h DEF throughout the reperfusion period). H P , 0.05 vs. sham-levels by approximately 37% (P , 0.05, N 5 12 to 14;
operated group (SHAM). 1P , 0.05 vs. control group (CONT, 45-min
Fig. 1A) and creatinine concentrations by approximately ischemia and 6-h reperfusion).
40% (P , 0.05, N 5 12 to 14; Fig. 1B). The administration
of DEF produced similar, significant reductions in plasma
urea and creatinine concentrations of approximately 32%
and tempol was not significantly different from those(P , 0.05, N 5 12 to 14) and 36% (P , 0.05, N 5 12
obtained upon administration of tempol or DEF alone.to 14), respectively, compared with control plasma urea
and creatinine concentrations (Fig. 1). The administra-
Effect of tempol and DEF on ischemia/tion of DEF with tempol also produced significant reduc-
reperfusion-mediated tubular dysfunction and injurytions in plasma urea and creatinine concentrations (Fig. 1).
Fractional excretion of sodium, calculated using plasmaThe combined administration of DEF and tempol sig-
Na1 concentrations, urine production (urine flow, mL/nificantly reduced plasma urea from 33 6 2 (controls) to
min) and urinary concentrations of Na1, was used as an21 6 1 mmol/L (DEF/tempol; N 5 12 to 14, P , 0.05;
indicator of PT function (Fig. 2A). FENa remained at ap-Fig. 1A). Plasma creatinine concentrations were also sig-
proximately 1% when calculated from sham-operatednificantly reduced from 212 6 10 (controls) to 155 6 6
rats (0.99 6 0.35%, N 5 11; Fig. 2A). However, ischemiammol/L (DEF/tempol; N 5 12 to 14, P , 0.05; Fig. 1B).
for 45 minutes followed by 6 hours of reperfusion pro-However, the degree of reduction in either plasma urea
or creatinine afforded by the coadminstration of DEF duced an approximately 38-fold increase in FENa to 38 6
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Administration of tempol prior to and during reperfu-
sion significantly decreased FENa by approximately 69%
compared with control values, from 38 6 3% (controls;
N 5 14) to 12 6 2% (tempol; N 5 12, P , 0.05; Fig.
2A). Tempol also significantly decreased urinary NAG
levels by approximately 60% compared with control val-
ues, from 43 6 5 (controls; N 5 14) to 18 6 2 U/L
(tempol; N 5 12, P , 0.05; Fig. 2B). The administration
of DEF produced similar effects on FENa and NAG; DEF
produced a significant decrease in FENa of 65% from 38
6 3% (controls; N 5 14) to 13 6 2% (DEF; N 5 12,
P , 0.05; Fig. 2A) and in NAG of 80% from 43.5 6 4.5
(controls; N 5 14) to 9 6 2 U/L (DEF; N 5 12, P ,
0.05; Fig. 2B). Coadminstration of DEF and tempol also
produced significant reductions in FENa and urinary
NAG concentrations (Fig. 2). This combination of DEF
and tempol significantly reduced FENa from 38 6 3%
(controls) to 19 6 2% (DEF/tempol; N 5 12 to 14, P ,
0.05; Fig. 2A). Urinary NAG levels were also signifi-
cantly reduced from 43 6 5 (controls) to 26 6 1 U/L
(DEF/tempol; N 5 12 to 14, P , 0.05; Fig. 2B). However,
the reduced values for FENa and NAG obtained using
DEF and tempol in combination were not significantly
different from those obtained upon administration of
tempol or DEF alone.
Effect of tempol and DEF on ischemia/
reperfusion-mediated renal reperfusion injury
Plasma concentrations of gGT and AST were both
used as markers of renal reperfusion injury in this model.
gGT increased by approximately ninefold from 0.6 6
Fig. 2. Effect of renal ischemia/reperfusion on (A) fractional excretion
0.3 (sham-operated) to 5.3 6 0.6 U/L (controls; N 5 11of Na1 (FENa) and (B) urinary excretion of NAG in the presence of
tempol (TEMP, 30 mg/kg IV bolus injection followed by infusion of to 14, P , 0.05; Fig. 3A). Plasma AST also increased by
30 mg/kg/h throughout the reperfusion period) or DEF (40 mg/kg IV ninefold from 170 6 12 (sham-operated) to 1436 6 178
bolus injection followed by infusion of 40 mg/kg/h) or a combination
U/L (controls; N 5 11 to 14, P , 0.05; Fig. 3B). However,of both tempol and DEF (30 mg/kg tempol/40 mg/kg DEF IV bolus
injection followed by infusion of 30 mg/kg/h tempol/40 mg/kg/h DEF renal ischemia/reperfusion did not have a significant ef-
throughout the reperfusion period). H P , 0.05 vs. sham-operated group fect on plasma BIL or ALT concentrations, respective
(SHAM). 1P , 0.05 vs. control group (CONT, 45-min ischemia and
markers of hepatic function and injury (data not shown).6-h reperfusion).
The administration of tempol or DEF produced sig-
nificant reductions in plasma gGT and AST compared
with values obtained from control animals (Fig. 3). Tem-
3% (controls; N 5 14, P , 0.05; Fig. 2A), indicating pol significantly reduced plasma gGT and AST levels by
significant PT dysfunction. In sham-operated animals, approximately 87 and 63%, respectively (P , 0.05, N 5
none of the interventions studied had any significant 12 to 14; Fig. 3). DEF also significantly reduced plasma
effect on urine production, plasma Na1, or urinary Na1 gGT and AST levels by approximately 70 and 56%,
concentrations, respectively [urine flow, 0.013 6 0.001 respectively (P , 0.05; Fig. 3). Coadminstration of DEF
mL/min (0.001 to 0.042 mL/min, N 5 79); plasma Na1, and tempol also produced significant reductions in both
142 6 0.4 mmol/L (133 to 150 mmol/L), N 5 79; urinary plasma gGT and AST concentrations (Fig. 3). This com-
Na1, 152 6 7.6 mmol/L (39 to 405 mmol/L), N 5 79]. bination of DEF and tempol significantly reduced gGT
Renal ischemia/reperfusion produced significant increases from 5.3 6 0.6% (controls) to 0.7 6 0.2 U/L (DEF/
in the urinary concentrations of NAG, suggesting signifi- tempol; N 5 12 to 14, P , 0.05; Fig. 3A) and AST from
cant tubular injury (Fig. 2B). After six hours of reperfu- 1436 6 178 (controls) to 603 6 58 U/L (DEF/tempol;
sion, urinary levels of NAG increased threefold from N 5 12 to 14, P , 0.05; Fig. 3B). However, the reduced
13.9 6 1.28 (sham-operated) to 43.5 6 4.5 U/L (controls; values for plasma gGT and AST obtained using DEF
and tempol in combination were not significantly differ-N 5 11 to 14, P , 0.05; Fig. 2B).
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Fig. 4. Effect of renal ischemia/reperfusion on (A) kidney myeloperox-
idase (MPO) activity and (B) kidney malondialdehyde (MDA) levelsFig. 3. Alterations in (A) plasma g-glutamyl transferase (gGT) and in the presence of tempol (TEMP, 30 mg/kg IV bolus injection followed(B) plasma aspartate aminotransferase (AST) during renal ischemia/ by an infusion of 30 mg/kg/h throughout the reperfusion period) orreperfusion in the presence of tempol (TEMP, 30 mg/kg IV bolus DEF (40 mg/kg IV bolus injection followed by infusion of 40 mg/kg/h),injection followed by infusion of 30 mg/kg/h throughout the reperfusion or a combination of both tempol and DEF (30 mg/kg tempol/40 mg/kgperiod) or DEF (40 mg/kg IV bolus injection followed by infusion of DEF IV bolus injection followed by an infusion of 30 mg/kg/h tempol/4040 mg/kg/h) or a combination of both tempol and DEF (30 mg/kg mg/kg/h DEF throughout the reperfusion period). H P , 0.05 vs. sham-tempol/40 mg/kg DEF IV bolus injection followed by infusion of 30 operated group (SHAM). 1P , 0.05 vs. control group (CONT, 45-minmg/kg/h tempol/40 mg/kg/h DEF throughout the reperfusion period). ischemia and 6-h reperfusion).
H P , 0.05 vs. sham-operated group (SHAM). 1P , 0.05 vs. control
group (CONT, 45-min ischemia and 6-h reperfusion).
60 6 3 (sham-operated) to 354 6 30 (controls) mU/100
mg wet tissue (N 5 11 to 14, P , 0.05; Fig. 4A). However,ent from those obtained upon administration of tempol
treatment of rats with tempol produced a significant at-or DEF alone.
tenuation of MPO activity caused by ischemia/reperfu-Administration of tempol or DEF to sham-operated
sion of the kidney, from 354 6 30 (controls) to 118 6animals did not have any effect on any plasma or urinary
10 (tempol) mU/100 mg wet tissue (N 5 12 to 14, P ,biochemical parameters that were similar to those ob-
0.05; Fig. 4A). DEF produced a similar significant reduc-tained from sham-operated animals (data not shown).
tion in MPO activity from 354 6 30 (controls) to 104 6
Effects of tempol and DEF on kidney MPO activity 7 (DEF) mU/100 mg wet tissue (N 5 12 to 14, P , 0.05;
and MDA levels Fig. 4A). The administration of the combination of DEF
and tempol also produced a significant attenuation ofRats subjected to renal ischemia/reperfusion exhibited
MPO activity from 354 6 30 (controls) to 146 6 11a substantial increase in MPO activity and MDA levels
(DEF/tempol) mU/100 mg wet tissue (N 5 12 to 14,in the kidney (Fig. 4). Renal ischemia/reperfusion pro-
duced a significant increase in kidney MPO activity from P , 0.05; Fig. 4A). However, this was not significantly
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different from the reduction in MPO activity obtained
upon administration of tempol or DEF alone.
Renal ischemia/reperfusion also produced a significant
increase in kidney MDA levels from 77 6 15 (sham
operated) to 260 6 23 (controls) mmol/L/100 mg wet
tissue (N 5 11 to 14, P , 0.05; Fig. 4B). Treatment of
rats with tempol produced a significant reduction of
MDA levels produced by ischemia/reperfusion, from
260 6 23 (controls) to 105 6 10 (tempol) mmol/L/100
mg wet tissue (N 5 12 to 14, P , 0.05; Fig. 4B). DEF
also produced a similar significant reduction in MDA
levels from 260 6 23 (controls) to 120 6 17 (DEF) mmol/
L/100 mg wet tissue (N 5 12 to 14, P , 0.05; Fig. 4B).
The administration of the combination of DEF and tem-
pol also produced a significant attenuation of MDA lev-
els, from 260 6 23 (controls) to 154 6 15 (DEF/tempol)
mmol/L/100 mg wet tissue (N 5 12 to 14, P , 0.05;
Fig. 4B). This reduction in MDA was not, however, sig-
nificantly different from the reduction obtained upon
administration of tempol or DEF alone.
The administration of tempol or DEF to sham-oper-
ated animals did not have any effect on kidney MPO
activity or MDA levels, which were similar to those ob-
tained from sham-operated animals (data not shown).
Effects of tempol and DEF on ischemia/
reperfusion-mediated renal histopathology
Fig. 5. Histologic evaluation of renal ischemia/reperfusion. Histology
On comparison with normal tubular histology in sham- of a normal proximal tubule (A) is compared with tubules revealing
brush border loss, nuclear condensation, and cytoplasmic swelling, andoperated rats (Fig. 5A), animals that underwent renal
loss of nuclei in up to one third of the tubular profile (B). More severeischemia/reperfusion demonstrated the recognized fea-
cellular loss, with between one third and two thirds of the tubular profile
tures of severe acute tubular damage (Fig. 5D) [37]. These denuded of nuclei (C) and greater than two thirds of nuclei lost (D)
are also represented (HandE, 3700). (E ) Effect of renal ischemia/features included brush border loss, nuclear condensation,
reperfusion on total severity score in the presence of tempol (TEMP,cytoplasmic swelling, and consistent loss of significant
30 mg/kg intravenous bolus injection followed by infusion of 30 mg/
numbers of nuclei from tubular profiles (Fig. 5D). kg/h throughout the reperfusion period) or DEF (40 mg/kg intravenous
bolus injection followed by infusion of 40 mg/kg/h), or a combinationTotal severity score was significantly reduced in rats
of both tempol and DEF (30 mg/kg tempol/40 mg/kg DEF IV bolusadministered tempol from 223 6 14 (controls) to 109 6
injection followed by infusion of 30 mg/kg/h tempol/40 mg/kg/h DEF
26 (tempol; N 5 6 to 12, P , 0.05; Fig. 5E). The adminis- throughout the reperfusion period). The Methods section explains the
scoring system used. H P , 0.05 vs. sham-operated group (SHAM). 1P ,tration of DEF had a similar significant effect on total
0.05 vs. control group (CONT, 45-min ischemia and 6-h reperfusion).severity score, reducing it from 223 6 14 (controls) to
133 6 23 (DEF; N 5 6 to 12, P , 0.05; Fig. 5E), as did
coadministration of DEF and tempol [from 223 6 14
(controls) to 145 6 31 (DEF/tempol), N 5 6 to 12, P , served in the kidney sections obtained from rats adminis-
tered tempol or DEF (Fig. 6 B, C).0.05; Fig. 5E]. Coadministration of DEF and tempol did
not have any additive effects on reduction of total sever- Kidneys obtained from rats subjected to ischemia/
reperfusion also demonstrated marked staining fority score on comparison with that obtained after tempol
or DEF administration, respectively. PARS, which was also localized to the PT (Fig. 7A).
Kidneys obtained from rats administered tempol or DEF
Immunohistochemical localization of nitrotyrosine demonstrated markedly reduced staining for PARS
and PARS formation upon comparison with kidneys obtained from control
animals (Fig. 7 B, C), suggesting a reduction in the activa-Immunohistochemical analysis of renal sections ob-
tained from rats subjected to renal ischemia/reperfusion tion of PARS after six hours of reperfusion.
No evidence of staining for either nitrotyrosine orinjury revealed positive staining for nitrotyrosine, which
was primarily localized to the PT, although some staining PARS was observed in kidney tissues obtained from
sham-operated rats administered saline, tempol, or DEFwas also observed in the macula densa structures (Fig.
6A). In contrast, substantially reduced staining was ob- (data not shown).
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Fig. 6. Immunohistochemical localization of nitrotyrosine in rat kidney.
(A) Control group (45-min ischemia and 6-h reperfusion). Nitrotyrosine Fig. 7. Immunohistochemical localization of poly(ADP-ribose) syn-
immunoreactivity was localized mainly to the PT with some staining of thetase (PARS) in a rat kidney. (A) Control group (45-min ischemia
the macula densa (typical areas indicated by arrows). In comparison, and 6-h reperfusion). PARS immunoreactivity was localized to the PT
the nitrotyrosine immunoreactivity of kidneys from rats treated with (typical areas indicated by arrows). PARS immunoreactivity of kidneys
(B) tempol and (C) DEF was markedly reduced (original magnification from rats treated with (B) tempol, and (C) DEF was markedly reduced
3125). This figure is representative of at least three experiments per- on comparison with staining obtained from the control group (original
formed on different experimental days. magnification 3125). This figure is representative of at least three exper-
iments performed on different experimental days.
Isolation, culture, and characterization of rat PT cells
use of MEM throughout culture in which l-valine wasOn removal from Percoll and observation under light
substituted with d-valine [38]. As discussed previouslymicroscope, the 1.060 g/mL band was found to consist
[35], suspensions and cultures of rat PT cells obtainedof both single and small two- to four-cell clumps of PT,
using the isolation method described here have beenin keeping with the findings of others [33, 34]. Once
previously characterized using phase-contrast and elec-confluent, cultures of PT cells demonstrated the typical
tron-scanning microscopy, enzyme histochemistry, and“cobblestone” morphology associated with epithelial
the demonstration of PT-specific transport mechanismscells. These cultures did not exhibit any evidence of
fibroblast contamination, which was prevented by the (for example, d-glucose and anionic/cationic transport)
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[33, 34]. These studies have demonstrated that the cells
isolated using this technique are of PT origin and main-
tain PT specific properties throughout culture and during
experiments performed using primary cultures.
H2O2-mediated rat PT cell injury and necrosis
Incubation of rat PT cell cultures with 1 mmol/L H2O2
for four hours produced a significant decrease in mito-
chondrial respiration, as determined by using the MTT
assay (Fig. 8) and a significant increase in the release of
LDH into the cell supernatant (Fig. 9). In the presence of
1 mmol/L H2O2 for four hours, mitochondrial respiration
decreased from 100 (untreated controls) to 24 6 1% of
control (N 5 12, P , 0.05; Fig. 9A) and caused a signifi-
cant release of LDH into the incubation medium, as
demonstrated by using the LDH assay from 0 (untreated
controls) to 65 6 2% Triton X-100 control (N 5 12, P ,
0.05; Fig. 9A).
Attenuation of H2O2-mediated cellular injury
by tempol and DEF
As described earlier in this article and previously [35],
incubation of rat PT cells with 1 mmol/L H2O2 for four
hours produced a significant, but submaximal, cellular in-
jury and cell death. The effects of tempol and DEF were
therefore investigated after incubation with 1 mmol/L
H2O2 for this time period. Furthermore, the effects of
coincubation of DEF and tempol, each at concentrations
that provided maximal reduction in cellular injury and
death when used individually, were also investigated.
Incubation with increasing concentrations of tempol
(0.03 to 10 mmol/L) resulted in a reduction in H2O2-
mediated decrease in mitochondrial respiration (Fig.
8A), which was significant at concentrations of 1 and 3
mmol/L [from 25 6 1 (H2O2 control) to 37 6 3 (3 mmol/L
tempol) percentage of control; N 5 6, P , 0.05; Fig.
8A]. Incubation with increasing concentrations of DEF
(0.03 to 10 mmol/L) also attenuated the fall in mitochon-
drial respiration mediated by H2O2 (Fig. 8B). Incubation
with DEF produced a significant reduction in H2O2-medi-
ated inhibition of mitochondrial respiration at 1, 3, and
10 mmol/L DEF [25 6 1 (H2O2-control) to 49 6 6 (3
Fig. 8. Effect of increasing concentrations of tempol, DEF and tempol/mmol/L DEF) percentage of control; N 5 6, P , 0.05;
DEF combination on H2O2-mediated cellular injury (MTT assay). RatFig. 8B]. Incubation of PT cell cultures with DEF and PT cells were incubated with H2O2 (1 mmol/L for 4 h) in the absence
(CONT) or presence of increasing concentrations of (A) tempol (0.03tempol in combination also significantly reduced the
to 10 mmol/L, N 5 12), (B) DEF (0.03 to 10 mmol/L, N 5 12), (C) inH2O2-mediated reduction in mitochondrial respiration the presence of tempol (TEMP, 3 mmol/L, N 5 18) or DEF (3 mmol/L,
[22 6 1 (H2O2-control) to 45 6 3 (3 mmol/L DEF 1 3 N 5 18, or a combination of both tempol and DEF (3 mmol/L tempol/3
mmol/L DEF; N 5 6). H P , 0.05 vs. H2O2-control (CONT, solidmmol/L tempol) percentage of control; N 5 6, P , 0.05;
column).
Fig. 8C]. However, this attenuation of H2O2-mediated
reduction in mitochondrial respiration was not signifi-
cantly different from that obtained using 3 mmol/L tem-
pol or 3 mmol/L DEF (Fig. 8C).
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Attenuation of H2O2-mediated cellular necrosis by
tempol and DEF
Incubation with increasing concentrations of tempol
(0.03 to 10 mmol/L) produced a decrease in H2O2-medi-
ated LDH release (Fig. 9A). A significant reduction in
LDH release was obtained using tempol at concentra-
tions of 1 and 3 mmol/L [from 65 6 3 (H2O2-control)
to 44 6 3 (3 mmol/L tempol) percentage Triton X-100
control; N 5 6, P , 0.05; Fig. 9A]. DEF (0.03 to 3
mmol/L) also attenuated LDH release produced by incu-
bation with 1 mmol/L H2O2 for four hours (Fig. 9B).
This reduction was found to be significant using DEF
concentrations of 1, 3, and 10 mmol/L [65 6 3 (H2O2-
control) to 39 6 3 (3 mmol/L DEF) percentage Triton
X-100 control; N 5 6, P , 0.05; Fig. 9B]. Incubation of
PT cell cultures with DEF and tempol in combination
also significantly reduced the H2O2-mediated increase in
LDH release [69 6 4 (H2O2-control) to 39 6 5 (3 mmol/L
DEF 1 3 mmol/L tempol) percentage Triton X-100 con-
trol; N 5 6, P , 0.05; Fig. 9C]. However, this reduction
of H2O2-mediated increase in LDH release was not sig-
nificantly different from that obtained using 3 mmol/L
tempol or 3 mmol/L DEF (Fig. 9C).
DISCUSSION
There is good evidence from both in vivo and in vitro
studies that ROS plays an important role in the patho-
physiology of renal ischemia/reperfusion injury [5]. We
demonstrate here, to our knowledge for the first time,
that administration prior to and during reperfusion of
the stable nitroxide radical tempol reduces the renal
dysfunction and injury caused by ischemia/reperfusion
of the rat kidney. We also report that tempol reduces
the cellular injury and death of PT cell cultures caused
by H2O2-mediated oxidant stress. These conclusions are
supported by the following key findings that in an in
vivo rat model of renal ischemia/reperfusion injury, ad-
ministration of tempol significantly reduced the ische-
mia/reperfusion-mediated increases in: (1) plasma levels
of urea and creatinine; (2) FENa and urinary NAG con-
centrations; (3) plasma levels of gGT and AST; and (4)
MPO activity and the levels of MDA in the kidney. Tem-
pol significantly reduced the histologic evidence of isch-Fig. 9. Effect of increasing concentrations of tempol, DEF and tempol/
DEF combination on H2O2-mediated cell death (LDH assay). Rat PT emia/reperfusion-mediated tubular injury and reduced the
cells were incubated with H2O2 (1 mmol/L for 4 h) in the absence immunohistochemical evidence of nitrotyrosine produc-(CONT) or presence of increasing concentrations of (A) tempol (0.03
tion and the activation of PARS. Using primary culturesto 10 mmol/L, N 5 12), (B) DEF (0.03 to 10 mmol/L, N 5 12) or (C)
in the presence of tempol (TEMP, 3 mmol/L, N 5 18) or DEF (3 of rat PT cells, this study also demonstrated that tempol
mmol/L, N 5 18, or a combination of both tempol and DEF (3 mmol/L attenuated both the impairment in mitochondrial respi-tempol/3 mmol/L DEF, N 5 6). H P , 0.05 vs. H2O2-control (CONT,
ration as well as the release of LDH caused by H2O2.solid column).
Since it is not valid to use clearance methods for the
assessment of glomerular filtration rate (GFR) in renal
models that involve extensive tubular injury such as the
one used here, GFR, estimated using creatinine clear-
ance, was not measured in this study. However, indica-
Chatterjee et al: Tempol reduces renal dysfunction and injury670
tors of glomerular function in the forms of plasma con- Reactive oxygen species also causes strand breaks in
DNA, which trigger energy-consuming DNA repaircentrations of urea and creatinine were measured, and
the significant increase in both subsequent to ischemia/ mechanisms and activate the nuclear enzyme PARS. As
described previously [32, 35], activation of PARS resultsreperfusion suggests moderate but significant impaired
glomerular function [23, 24]. Furthermore, ischemia/ in the depletion of its substrate NAD and also in a reduc-
tion in the rate of glycolysis. As NAD functions as areperfusion resulted in significant increase in both FENa
and urinary NAG (a specific marker for tubular injury cofactor in glycolysis and the tricarboxylic acid cycle,
NAD depletion leads to a rapid fall in intracellular ATP.and possibly function) [27], suggesting a reduction in
tubular function and increased tubular injury, respec- The substantial decrease in NAD and ATP concentra-
tions lead to cellular dysfunction and death, and thetively. Renal ischemia/reperfusion also produced sig-
nificant increases in plasma concentrations of gGT and overall process has been termed “the PARS Suicide Hy-
pothesis” [43]. We have recently discovered that theAST, which were used in this study as markers of renal
reperfusion injury. Both enzymes are present within the activation of PARS plays an important role in both ische-
mia/reperfusion dysfuction and injury of the kidney inPT [25] and can be released into the urine subsequent
to renal injury [39, 40]. However, it is also feasible that vivo [32] and in the cellular injury and death caused by
H2O2 in rat PT cell cultures [35]. Using immunohisto-their increased plasma levels subsequent to renal ische-
mia/reperfusion originated from the kidney after damage chemistry, we demonstrate in this study that ischemia/
reperfusion of the rat kidney in vivo leads to an increaseto the tubular architecture. Both enzymes are regarded
as nonspecific markers of extensive cellular disruption in PARS activity.
Taken together, the evidence presented in this studyor necrosis [24], and one could argue that these enzymes
are also released from the liver after hepatic injury subse- suggests that ischemia/reperfusion of rat kidneys pro-
duces moderate glomerular dysfunction, but a substan-quent to renal ischemia/reperfusion, presumably caused
by circulating mediators. However, plasma levels of total tial increase in tubular dysfunction and injury. This is in
keeping with the notion that ischemia/reperfusion of theBIL (a marker of hepatocellular injury and dysfunction)
[26] and AST (a specific marker of hepatic parenchymal kidney causes both glomerular and tubular dysfunction
[44]. There are several reports describing the vulnerabil-injury) [26] were also measured, and in this study, these
did not show a significant increase subsequent to renal ity of the outer medulla and thick ascending limb cells
to structural damage during renal ischemia/reperfusion,ischemia/reperfusion. Furthermore, plasma concentra-
tions of gGT have been shown not to rise in primary which has been attributed to the imbalance in metabolic
demand of this region of the kidney and oxygen deliveryhepatocyte necrosis [24].
Renal ischemia/reperfusion also caused a significant to these cells [45–47]. Although it is important to con-
sider the role of glomerular dysfunction and injury asincrease in MPO activity, indicating PMN accumulation,
and in MDA levels, indicating increased lipid peroxida- well as the pathophysiology of the renal medulla during
episodes of renal ischemia/reperfusion, early observa-tion and, therefore, increased oxidative stress. Histologic
examination of kidney sections showed increased evi- tions, among several others, have suggested that the dam-
age to kidney during ischemia/reperfusion is primarilydence of tubular injury subsequent to ischemia/reperfu-
sion, and this was reflected by a significant increase in to the S3 segment of the PT [48]. This was further rein-
forced by the demonstration in this study that (1) renalthe total severity score obtained from sections of kidney
from rats that underwent ischemia/reperfusion. Renal ischemia/reperfusion in vivo caused relatively greater
tubular dysfunction and injury than glomerular dysfunc-ischemia/reperfusion also increased the nitration of pro-
teins (as determined by measurement of nitrotyrosine tion, and that (2) oxidant stress in the form of H2O2
produced significant levels of cellular injury and deathformation using immunohistochemistry). Nitrotyrosine
formation, along with its detection using immunohisto- in primary cultures of rat PT cells in vitro.
Our study demonstrates, to our knowledge for thechemical staining, was initially proposed as a relatively
specific marker for the detection or “footprint” of the first time, that tempol (1) reduces the degree of renal
dysfunction and injury caused by ischemia/reperfusionendogenous formation of peroxynitrite [41]. There is,
however, recent evidence that certain other reactions of the rat kidney in vivo, and (2) reduces the cellular
injury and death caused by H2O2 in primary cultures ofcan also induce tyrosine nitration. For example, the reac-
tion of nitrite with hypochlorous acid and the reaction rat PT cells in vitro. Tempol is a stable piperidine ni-
troxide and a water-soluble analogue of the spin labelof MPO with H2O2 can lead to the formation of nitrotyro-
sine [42]. Therefore, increased nitrotyrosine staining is tempo that has a relatively low molecular weight (172),
permeates biological membranes [13], and accumulatesnow considered to act as an indicator of “increased nitro-
sative stress” rather than a specific marker of the genera- in the cytosol [16]. Tempol has a very short half-life and
is rapidly bioreduced in the rat in vivo [49], and this wastion of peroxynitrite.
Chatterjee et al: Tempol reduces renal dysfunction and injury 671
the basis for the infusion protocol used for the adminis- differences between the reduction in oxidative stress-
tration of tempol in this study. Tempol is reduced by mediated renal or PT cell dysfunction and injury ob-
ascorbic acid but not by reduced glutathione into its tained using tempol and DEF. As tempol has been shown
inactive hydroloxamine metabolite [17]. However, tem- not to scavenge H2O2 [58, 61, 62], it is likely that tempol
pol, along with other nitroxides, can also be recycled prevented H2O2-mediated cell injury/death by reducing
back into its oxidized form, and their antioxidative activ- the generation, or the effects, of hydroxyl radicals. This
ity is associated to their ability to switch between oxi- is supported by the finding that coadministration of DEF
dized and reduced forms [50, 51]. Furthermore, tempol and tempol together did not provide any additional bene-
can also be produced in situ in rat liver upon metabolism ficial actions compared with that obtained using either
of tempone [52]. Tempol has been shown to cause tyro- tempol or DEF alone. Furthermore, it is unlikely that
sine phosphorylation, activation of Raf-1 protein kinase tempol affects the activity of xanthine oxidase, as similar
and an increase extracellular signal-regulated kinase 1 compounds, including tempo and the SOD-mimetic tiron,
activity in human MDA-MB-231 breast cancer cells [53]. do not affect the activity of this enzyme [63].
In a rat model of cerebral injury, reducing tumor necrosis As tempol attenuated the nitration of proteins (as
factor-a toxicity is possible by interfering with the activa- determined using immunohistochemical localization of
tion of transcription factor nuclear factor-kB [54]. nitrotyrosine formation) in the kidney of rats subjected
There is some evidence of toxicological actions associ- to ischemia/reperfusion injury, one could argue that the
ated with administration of tempol. Tempol has been prevention of “nitrosative stress” plays an important part
reported to cause dose-related hypotension accompa- in the reduction by tempol of renal ischemia/reperfusion
nied by reflex tachycardia [55], presumably by scaveng- injury. This is unlikely to be a major factor in our study,
ing of superoxide and thereby prolonging the presence of as the protection of the kidney caused by coadministra-
systemic nitric oxide (NO) levels leading to vasodilation. tion of DEF and tempol was not greater than the protec-
However, this hypotensive effect was used to combat the tion caused by either DEF or tempol alone, and it is there-
hypertension characteristic of SHR in a study where tem- fore likely that a greater degree of tissue injury is mediated
pol was administered to rats in their drinking water over by hydroxyl radicals. Hydroxyl radicals (and other ROS
a two week period [18]. In the same study, tempol did and peroxynitrite) cause strand breaks in DNA, which
not have any effect on the MAP when administered to trigger energy-consuming DNA repair mechanisms and
normal (Wistar-Kyoto) rats in a similar fashion [18], and activate the nuclear enzyme PARS. We have previously
at the concentrations used in this study, tempol did not demonstrated that H2O2, via the production of hydroxyl
have a significant effect on cardiovascular parameters radicals, leads to DNA strand breakage and the activation
(MAP/HR). Tempol has been reported to inhibit the of PARS in PT cell cultures [35]. We demonstrate here
growth of neoplastic human and rodent cell lines by apo- that ischemia/reperfusion of the rat kidney in vivo leads
ptosis [56] and to increase skin temperature [55], although to an increase in PARS activity (as demonstrated using
the relevance of these observations is not known. immunohistochemistry), which is significantly reduced by
It is intriguing to consider the mechanisms by which tempol. Thus, we propose that the prevention of the acti-
tempol reduces renal dysfunction and injury, and more vation of PARS also contributes to the beneficial effects
specifically, PT cell injury/death mediated by oxidative of tempol observed in our study.
stress-mediated renal injury. There is good evidence that In conclusion, this article demonstrates, to our knowl-
ROS contributes to renal injury [3, 5, 57]. Several studies edge for the first time, that tempol reduces the degree
have demonstrated how tempol scavenges superoxide of renal dysfunction and injury caused by ischemia/reper-
anions in vitro [11, 13, 58, 59] and how it may also act fusion of the rat kidney in vivo, and reduces the cell
as a genuine “SOD-mimetic” [14]. Tempol has also been injury/death caused by H2O2 in rat PT cells in vitro. Wereported to reduce the formation or the effects of hy-
propose that the beneficial effects of tempol observed
droxyl radicals by scavenging superoxide anions or by
in our study are due to its ability to reduce the generationreducing intracellular Fe21 concentrations or even by
or the effects of hydroxyl radicals.directly scavenging hydroxyl radicals [15–17]. In our
study, the renal dysfunction and injury produced during
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